Efficacy and safety of ovine reinforced tissue matrix for ventral hernia repair: a systematic review and meta-analysis.
Diego L Lima, Maria Clara Morais, Augusto Graziani E Sousa et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated the efficacy and safety of OviTex, a reinforced tissue matrix, for ventral hernia repair in 534 patients. The study found that OviTex significantly reduced recurrence rates (RR 0.45; 95% CI 0.22 to 0.94; p=0.03) compared to synthetic or other biologic meshes, with no significant differences in surgical site occurrences or length of stay.
Key findings
- OviTex reduced hernia recurrence rates significantly (RR 0.45; 95% CI 0.22 to 0.94; p=0.03).
- Overall primary fascial closure rate was 88%.
- No significant differences in surgical site occurrences (RR 1.27; p=0.32) or length of stay (MD 3.18 days; p=0.51).
Why it matters
The findings suggest that OviTex may be a preferable option for ventral hernia repair, particularly in patients with increased risk factors or prior mesh infections, potentially leading to improved patient outcomes.
What to keep in mind
The analysis is based on a limited number of observational studies, necessitating further prospective research for confirmation.